Clinical research
Being tested in people in registered clinical trials. Being in trials is not evidence that a treatment works or is safe.
Apa yang diuji dalam uji klinis ini
A large late-stage trial testing whether a single infusion of a CRISPR treatment, which switches off a gene in the liver, helps people whose hearts are being damaged by amyloid deposits. In 2025 a participant died of liver failure after dosing; the trial was paused and placed on hold by the FDA, and the hold was later lifted.
A global Phase 3 study of nexiguran ziclumeran, a lipid-nanoparticle CRISPR-Cas9 therapy knocking out hepatic TTR, in participants with ATTR cardiomyopathy. Following a serious hepatic adverse event and death in a participant in his early eighties, Intellia voluntarily paused dosing and screening; the FDA imposed a clinical hold, which was subsequently lifted for this study.
Sources
- Intellia Therapeutics · 2025
Intellia provides update on MAGNITUDE clinical trials ↗ - Intellia Therapeutics · 2025
Intellia announces FDA lift of clinical hold on MAGNITUDE Phase 3 clinical trial in ATTR-CM ↗
Apa yang dimaksud dan tidak dimaksud oleh hasil uji klinis
Hasil fase awal berasal dari jumlah peserta yang kecil dan waktu tindak lanjut yang singkat. Hasilnya dapat berubah seiring bertambahnya peserta dan waktu, dan uji klinis yang sedang merekrut, aktif, atau bahkan sudah selesai belum membuktikan bahwa suatu pengobatan berhasil. Kriteria pendaftaran sangat ketat; kelayakan ditentukan oleh pihak uji klinis, bukan oleh sebuah situs web.